MedPath
NMPA Approval

Octreotide Acetate Injection

国药准字H20223960

December 30, 2022

Drug Information

醋酸奥曲肽注射液

注射剂

1ml:0.1mg(以C₄₉H₆₆N₁₀O₁₀S₂计)

化学药品

December 30, 2022

Company Information

Applicant Company

海南省澄迈县老城镇高新技术产业示范区海南生态软件园沃克公园C8855幢四层B区

Manufacturing Company

哈尔滨市利民开发区北京路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

醋酸奥曲肽注射液 - NMPA 批准文号 | MedPath